Y-mAbs Therapeutics Inc.

4.13
0.01 (0.24%)
At close: Apr 24, 2025, 3:59 PM
4.07
-1.50%
After-hours: Apr 24, 2025, 05:54 PM EDT

Y-mAbs Therapeutics Revenue

Y-mAbs Therapeutics reported an annual revenue of $87.69M, reflecting a 3.38% growth. For the quarter ending December 31, 2024, Y-mAbs Therapeutics generated $26.5M in revenue.
Revenue (ttm)
$87.69M
Revenue Growth
3.38%
Price / Sales Ratio
3.96
Revenue / Employee
$843.13K
Employees
104
Market Cap
186.76M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 87.69M +3.38%
Dec 31, 2023 84.82M +29.96%
Dec 31, 2022 65.27M +87.03%
Dec 31, 2021 34.9M +68.18%
Dec 31, 2020 20.75M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.